KENCANA AGRI LIMITED ANNUAL REPORT 2025
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group | 2024Group | Source |
|---|---|---|---|
| Profit or loss | |||
| RevenueUS$'000 | 198,652 | 153,734 | PDF p. 31 |
| Cost of salesUS$'000 | (142,998) | (110,397) | PDF p. 31 |
| Gross profitUS$'000 | 55,654 | 43,337 | PDF p. 31 |
| Interest incomeUS$'000 | 422 | 378 | PDF p. 31 |
| Other gainsUS$'000 | 1,982 | 3,324 | PDF p. 31 |
| Changes in fair value of biological assets and plasma receivablesUS$'000 | (3,379) | 5,894 | PDF p. 31 |
| Distribution costsUS$'000 | (2,683) | (1,931) | PDF p. 31 |
| Administrative expensesUS$'000 | (9,733) | (9,732) | PDF p. 31 |
| Finance costsUS$'000 | (13,102) | (15,452) | PDF p. 31 |
| Other lossesUS$'000 | (4,385) | (3,093) | PDF p. 31 |
| Profit before taxUS$'000 | 24,776 | 22,725 | PDF p. 31 |
| Income tax expenseUS$'000 | (6,334) | (10,783) | PDF p. 31 |
| Net profit for the yearUS$'000 | 18,442 | 11,942 | PDF p. 31 |
| Other comprehensive income | |||
| Exchange differences on translating group entities’ functional currency to US$ presentation currency, net of taxUS$'000 | (1,937) | (1,942) | PDF p. 31 |
| Remeasurements of defined benefit pension plans, net of taxUS$'000 | (553) | 347 | PDF p. 31 |
| Other comprehensive loss for the year, net of taxUS$'000 | (2,490) | (1,595) | PDF p. 31 |
| Total net comprehensive income for the yearUS$'000 | 15,952 | 10,347 | PDF p. 31 |
| Earnings per share | |||
| Basic and dilutedCents | 6.43 | 4.16 | PDF p. 31 |
Original report: PDF p. 31 ↗
Exchange differences row label wraps across two lines; the quote is the second line carrying the values. Exchange differences are items that may be reclassified subsequently to profit or loss; remeasurements will not be reclassified.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group | 2024Group | 2025Company | 2024Company | Source |
|---|---|---|---|---|---|
| Non-current assets | |||||
| Property, plant and equipmentUS$'000 | 70,845 | 72,008 | – | – | PDF p. 31 |
| Right-of-use assetsUS$'000 | 232 | 278 | – | – | PDF p. 31 |
| Bearer plantsUS$'000 | 85,974 | 93,490 | – | – | PDF p. 31 |
| Investments in subsidiariesUS$'000 | – | – | 31,367 | 32,570 | PDF p. 31 |
| Land use rightsUS$'000 | 21,600 | 23,558 | – | – | PDF p. 31 |
| Deferred tax assetsUS$'000 | 2,752 | 3,442 | – | – | PDF p. 31 |
| Other receivablesUS$'000 | 5,982 | 4,211 | – | – | PDF p. 31 |
| Total non-current assetsUS$'000 | 187,385 | 196,987 | 31,367 | 32,570 | PDF p. 31 |
| Current assets | |||||
| Biological assetsUS$'000 | 23,198 | 27,646 | – | – | PDF p. 31 |
| InventoriesUS$'000 | 15,361 | 15,294 | – | – | PDF p. 31 |
| Trade and other receivablesUS$'000 | 9,232 | 20,481 | 34,231 | 35,497 | PDF p. 31 |
| Other non-financial assetsUS$'000 | 1,408 | 1,936 | – | 1 | PDF p. 31 |
| Cash and cash equivalentsUS$'000 | 26,974 | 25,967 | 56 | 50 | PDF p. 31 |
| Total current assetsUS$'000 | 76,173 | 91,324 | 34,287 | 35,548 | PDF p. 31 |
| Assets | |||||
| Total assetsUS$'000 | 263,558 | 288,311 | 65,654 | 68,118 | PDF p. 31 |
| Equity | |||||
| Share capitalUS$'000 | 93,860 | 93,860 | 93,860 | 93,860 | PDF p. 31 |
| Retained earnings (accumulated losses)US$'000 | 8,538 | (9,351) | (488) | (886) | PDF p. 31 |
| Other reserveUS$'000 | 2,400 | 2,400 | – | – | PDF p. 31 |
| Foreign exchange translation reserveUS$'000 | (47,921) | (45,984) | (37,452) | (35,316) | PDF p. 31 |
| Total equity attributable to owners of the companyUS$'000 | 56,877 | 40,925 | 55,920 | 57,658 | PDF p. 31 |
| Non-current liabilities | |||||
| Advances from customerUS$'000 | 2,700 | 8,411 | – | – | PDF p. 31 |
| Deferred tax liabilitiesUS$'000 | 3,316 | 3,484 | – | – | PDF p. 31 |
| Lease liabilitiesUS$'000 | 1,410 | 794 | – | – | PDF p. 31 |
| Other financial liabilitiesUS$'000 | 114,745 | 134,778 | – | – | PDF p. 31 |
| Other non-financial liabilitiesUS$'000 | 5,341 | 6,016 | – | – | PDF p. 31 |
| Total non-current liabilitiesUS$'000 | 127,512 | 153,483 | – | – | PDF p. 31 |
| Current liabilities | |||||
| Income tax payableUS$'000 | 5,905 | 2,571 | – | – | PDF p. 31 |
| Trade and other payablesUS$'000 | 33,086 | 34,547 | 9,734 | 10,460 | PDF p. 31 |
| Lease liabilitiesUS$'000 | 1,409 | 1,398 | – | – | PDF p. 31 |
| Other financial liabilitiesUS$'000 | 38,769 | 55,387 | – | – | PDF p. 31 |
| Total current liabilitiesUS$'000 | 79,169 | 93,903 | 9,734 | 10,460 | PDF p. 31 |
| Liabilities | |||||
| Total liabilitiesUS$'000 | 206,681 | 247,386 | 9,734 | 10,460 | PDF p. 31 |
| Equity and liabilities | |||||
| Total equity and liabilitiesUS$'000 | 263,558 | 288,311 | 65,654 | 68,118 | PDF p. 31 |
Original report: PDF p. 31 ↗
Total equity attributable to owners of the company label wraps across two lines; quote is the second line carrying the values.
The Company has no income statement presented in this report; only the Group statement of profit or loss is printed.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group | 2024Group | Source |
|---|---|---|---|
| Profit | |||
| Net profit for the yearUS$'000 | 18,442 | 11,942 | PDF p. 31 |
| Other comprehensive income - may be reclassified | |||
| Exchange differences on translating group entities’ functional currency to US$ presentation currency, net of taxUS$'000 | (1,937) | (1,942) | PDF p. 31 |
| Other comprehensive income - will not be reclassified | |||
| Remeasurements of defined benefit pension plans, net of taxUS$'000 | (553) | 347 | PDF p. 31 |
| Other comprehensive income | |||
| Other comprehensive loss for the year, net of taxUS$'000 | (2,490) | (1,595) | PDF p. 31 |
| Total | |||
| Total net comprehensive income for the yearUS$'000 | 15,952 | 10,347 | PDF p. 31 |
Original report: PDF p. 31 ↗
Company's separate statement of profit or loss and other comprehensive income is not presented (Companies Act 1967), per Note 1.
No non-controlling interests schedule presented; equity attributable to owners of the company only.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group - Total equity attributable to owners of the company | 2025Group - Share capital | 2025Group - Retained earnings (accumulated losses) | 2025Group - Other reserve | 2025Group - Reserve on post-employment benefits | 2025Group - Foreign exchange translation reserve | Source |
|---|---|---|---|---|---|---|---|
| Current year | |||||||
| Opening balance at 1 January 2025US$'000 | 40,925 | 93,860 | (9,351) | 2,400 | – | (45,984) | PDF p. 32 |
| Changes in equity | |||||||
| Total comprehensive income for the yearUS$'000 | 15,952 | – | 18,442 | – | (553) | (1,937) | PDF p. 32 |
| Transferred to retained earningsUS$'000 | – | – | (553) | – | 553 | – | PDF p. 32 |
| Current year | |||||||
| Closing balance at 31 December 2025US$'000 | 56,877 | 93,860 | 8,538 | 2,400 | – | (47,921) | PDF p. 32 |
Original report: PDF p. 32 ↗
(a) Other reserve relates to merger reserve arising from the acquisition of subsidiaries in prior years.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2024Group - Total equity attributable to owners of the company | 2024Group - Share capital | 2024Group - Retained earnings (accumulated losses) | 2024Group - Other reserve | 2024Group - Reserve on post-employment benefits | 2024Group - Foreign exchange translation reserve | Source |
|---|---|---|---|---|---|---|---|
| Previous year | |||||||
| Opening balance at 1 January 2024US$'000 | 30,578 | 93,860 | (21,640) | 2,400 | – | (44,042) | PDF p. 32 |
| Changes in equity | |||||||
| Total comprehensive income for the yearUS$'000 | 10,347 | – | 11,942 | – | 347 | (1,942) | PDF p. 32 |
| Transferred to accumulated lossesUS$'000 | – | – | 347 | – | (347) | – | PDF p. 32 |
| Previous year | |||||||
| Closing balance at 31 December 2024US$'000 | 40,925 | 93,860 | (9,351) | 2,400 | – | (45,984) | PDF p. 32 |
Original report: PDF p. 32 ↗
(a) Other reserve relates to merger reserve arising from the acquisition of subsidiaries in prior years.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Company - Total equity | 2025Company - Share capital | 2025Company - Accumulated losses | 2025Company - Foreign exchange translation reserve | Source |
|---|---|---|---|---|---|
| Current year | |||||
| Opening balance at 1 January 2025US$'000 | 57,658 | 93,860 | (886) | (35,316) | PDF p. 32 |
| Changes in equity | |||||
| Total comprehensive loss for the yearUS$'000 | (1,738) | – | 398 | (2,136) | PDF p. 32 |
| Current year | |||||
| Closing balance at 31 December 2025US$'000 | 55,920 | 93,860 | (488) | (37,452) | PDF p. 32 |
Original report: PDF p. 32 ↗
Units appear below each metric. Scroll to compare years
| Metric / unit | 2024Company - Total equity | 2024Company - Share capital | 2024Company - Accumulated losses | 2024Company - Foreign exchange translation reserve | Source |
|---|---|---|---|---|---|
| Previous year | |||||
| Opening balance at 1 January 2024US$'000 | 61,235 | 93,860 | (124) | (32,501) | PDF p. 32 |
| Changes in equity | |||||
| Total comprehensive loss for the yearUS$'000 | (3,577) | – | (762) | (2,815) | PDF p. 32 |
| Previous year | |||||
| Closing balance at 31 December 2024US$'000 | 57,658 | 93,860 | (886) | (35,316) | PDF p. 32 |
Original report: PDF p. 32 ↗
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group | 2024Group | Source |
|---|---|---|---|
| Cash flows from operating activities | |||
| Profit before taxUS$'000 | 24,776 | 22,725 | PDF p. 32 |
| Adjustments for | |||
| Interest incomeUS$'000 | (422) | (378) | PDF p. 32 |
| Interest expenseUS$'000 | 13,102 | 15,452 | PDF p. 32 |
| Amortisation of land use rightsUS$'000 | 1,106 | 1,066 | PDF p. 32 |
| Depreciation expenseUS$'000 | 14,679 | 14,569 | PDF p. 32 |
| Fair value changes in biological assetsUS$'000 | 3,485 | (5,053) | PDF p. 32 |
| Fair value changes in plasma receivablesUS$'000 | (106) | (841) | PDF p. 32 |
| (Reversal) provision for employment pension benefits (Note 29)US$'000 | (1,170) | 193 | PDF p. 32 |
| (Gain) loss on disposal of property, plant and equipmentUS$'000 | (61) | 135 | PDF p. 32 |
| Bearer plants written off (Note 16)US$'000 | 2,488 | 39 | PDF p. 32 |
| Reversal of long overdue payables to supplierUS$'000 | – | (726) | PDF p. 32 |
| Write-off of bad debtsUS$'000 | 36 | 150 | PDF p. 32 |
| Net effect of exchange rate changes in consolidating entitiesUS$'000 | 18 | 1,136 | PDF p. 32 |
| Cash flows from operating activities | |||
| Operating cash flows before changes in working capitalUS$'000 | 57,931 | 48,467 | PDF p. 32 |
| InventoriesUS$'000 | (643) | (3,081) | PDF p. 32 |
| Trade and other receivablesUS$'000 | 11,432 | 6,896 | PDF p. 32 |
| Other non-financial assetsUS$'000 | 464 | 1,050 | PDF p. 32 |
| Trade and other payablesUS$'000 | (6,350) | (17,384) | PDF p. 32 |
| Net cash flows from operationsUS$'000 | 62,834 | 35,948 | PDF p. 32 |
| Income taxes paidUS$'000 | (4,335) | (7,157) | PDF p. 32 |
| Net cash flows from operating activitiesUS$'000 | 58,499 | 28,791 | PDF p. 32 |
| Cash flows used in investing activities | |||
| Proceeds from disposal of property, plant and equipmentUS$'000 | 220 | – | PDF p. 32 |
| Purchase of property, plant and equipmentUS$'000 | (7,149) | (9,009) | PDF p. 32 |
| Additions to bearer plantsUS$'000 | (4,657) | (4,030) | PDF p. 32 |
| Acquisition of land use rightsUS$'000 | – | (1,495) | PDF p. 32 |
| Interest receivedUS$'000 | 422 | 378 | PDF p. 32 |
| Net cash flows used in investing activitiesUS$'000 | (11,164) | (14,156) | PDF p. 32 |
| Cash flows used in financing activities | |||
| Cash released from (allocated to) restricted accountUS$'000 | 6,015 | (4,448) | PDF p. 32 |
| Proceeds from borrowingsUS$'000 | 123,295 | 264,418 | PDF p. 32 |
| Repayment of borrowingsUS$'000 | (153,449) | (251,924) | PDF p. 32 |
| Repayments of lease liabilitiesUS$'000 | (1,834) | (826) | PDF p. 32 |
| Interest paidUS$'000 | (13,348) | (15,694) | PDF p. 32 |
| Net cash flows used in financing activitiesUS$'000 | (39,321) | (8,474) | PDF p. 32 |
| Net change in cash | |||
| Net increase in cash and cash equivalentsUS$'000 | 8,014 | 6,161 | PDF p. 32 |
| Net effect of exchange rate changes on cash and cash equivalentsUS$'000 | (480) | (259) | PDF p. 32 |
| Cash and cash equivalents, consolidated statement of cash flows, beginning balanceUS$'000 | 9,393 | 3,491 | PDF p. 32 |
| Cash and cash equivalents, consolidated statement of cash flows, ending balance (Note 24A)US$'000 | 16,927 | 9,393 | PDF p. 32 |
Original report: PDF p. 32 ↗
Only a consolidated (Group) cash flow statement is presented; no separate Company cash flow statement.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group FY2025 | 2024Group FY2024 | 2025Change (%), FY2025 vs FY2024 | Source |
|---|---|---|---|---|
| Summary of results | ||||
| RevenueUS$'000 (change in %) | 198,652 | 153,734 | 29.2 | PDF p. 5 |
| Gross profitUS$'000 (change in %) | 55,654 | 43,337 | 28.4 | PDF p. 5 |
| EBITDAUS$'000 (change in %) | 56,620 | 47,539 | 19.1 | PDF p. 5 |
Original report: PDF p. 5 ↗
(*) Earnings before interest, tax, depreciation and amortization (EBITDA) is calculated as follows: profit before tax + interest expense – interest income + depreciation and amortisation expenses +/- fair value changes in biological assets and other receivables
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group as at 31 Dec 2025 | 2024Group as at 31 Dec 2024 | 2023Group as at 31 Dec 2023 | Source |
|---|---|---|---|---|
| Balance sheet | ||||
| Current assetsUS$'000 | 76,173 | 91,324 | 82,421 | PDF p. 6 |
| Non-current assetsUS$'000 | 187,385 | 196,987 | 210,836 | PDF p. 6 |
| Total assetsUS$'000 | 263,558 | 288,311 | 293,257 | PDF p. 6 |
| Current liabilitiesUS$'000 | 79,169 | 93,903 | 104,383 | PDF p. 6 |
| Non-current liabilitiesUS$'000 | 127,512 | 153,483 | 158,296 | PDF p. 6 |
| Total liabilitiesUS$'000 | 206,681 | 247,386 | 262,679 | PDF p. 6 |
| Shareholders’ equityUS$'000 | 56,877 | 40,925 | 30,578 | PDF p. 6 |
| Ratios | ||||
| Net debt/Equity ratio (x)x | 2.3 | 4.1 | 5.6 | PDF p. 6 |
| Net debt/Total assets (x)x | 0.5 | 0.6 | 0.6 | PDF p. 6 |
| Net debt/EBITDA (x)x | 2.3 | 3.5 | 5.0 | PDF p. 6 |
| EBITDA/Interest expense (x)x | 4.3 | 3.1 | 2.3 | PDF p. 6 |
Original report: PDF p. 6 ↗
No definitions of the ratios are printed beside the table.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group FY2025 | 2024Group FY2024 | 2023Group FY2023 | Source |
|---|---|---|---|---|
| Cash flow | ||||
| Cash at the beginning of yearUS$'000 | 9,393 | 3,491 | 2,871 | PDF p. 6 |
| Net cash from operating activitiesUS$'000 | 58,499 | 28,791 | 40,352 | PDF p. 6 |
| Net cash used in investing activitiesUS$'000 | (11,164) | (14,156) | (12,470) | PDF p. 6 |
| Net cash used in financing activitiesUS$'000 | (39,321) | (8,474) | (27,217) | PDF p. 6 |
| Net increase in cashUS$'000 | 8,014 | 6,161 | 665 | PDF p. 6 |
| Net effect of exchange rate changes on cash and cash equivalentsUS$'000 | (480) | (259) | (45) | PDF p. 6 |
| Cash at end of yearUS$'000 | 16,927 | 9,393 | 3,491 | PDF p. 6 |
Original report: PDF p. 6 ↗
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group FY2025 | 2024Group FY2024 | 2023Group FY2023 | Source |
|---|---|---|---|---|
| Operational highlights | ||||
| PLANTED AREA (HA)Ha | 67,885 | 67,885 | 66,846 | PDF p. 7 |
| Production volume (MT) | ||||
| FFB ProductionMT | 785,833 | 680,478 | 775,280 | PDF p. 7 |
| FFB ProcessedMT | 898,505 | 767,321 | 818,624 | PDF p. 7 |
| Oil Production | ||||
| CPOMT | 187,295 | 163,489 | 171,467 | PDF p. 7 |
| Average FFB yield (MT/HA) | ||||
| NucleusMT/Ha | 13.6 | 11.5 | 13.1 | PDF p. 7 |
| PlasmaMT/Ha | 10.3 | 9.2 | 10.8 | PDF p. 7 |
| Oil extraction rates | ||||
| CPO% | 20.8 | 21.3 | 20.9 | PDF p. 7 |
| Sales volume (MT) | ||||
| CPOMT | 203,314 | 173,323 | 174,598 | PDF p. 7 |
| Average selling price (US$/MT) | ||||
| CPOUS$/MT | 832 | 785 | 698 | PDF p. 7 |
Original report: PDF p. 7 ↗
Planted profile (nucleus/plasma by age) with percentages also printed; only headline rows extracted.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group 2025 | 2024Group 2024 | Source |
|---|---|---|---|
| Numerators | |||
| Earnings attributable to equity holders (US$’000)US$'000 | 18,442 | 11,942 | PDF p. 41 |
| Weighted average number of equity shares (’000) | |||
| Basic and diluted (Note 25)'000 shares | 287,011 | 287,011 | PDF p. 41 |
| Earnings per share | |||
| Earnings per share (US$ cents)US$ cents | 6.43 | 4.16 | PDF p. 41 |
Original report: PDF p. 41 ↗
There is no dilution of earnings per share as there are presently no dilutive shares outstanding as at the end of the reporting year. The denominators used are the same as those detailed above for both basic and diluted earnings per share.
Where the money comes from
| Item / unit | 2025Revenue, US$'000 | 2024Revenue, US$'000 | 2025Non-current assets, US$'000 | 2024Non-current assets, US$'000 | Source |
|---|---|---|---|---|---|
| Geographical information | |||||
| IndonesiaUS$'000 | 198,652 | 153,734 | 176,148 | 186,800 | PDF p. 54 |
| SingaporeUS$'000 | – | – | 2,503 | 2,534 | PDF p. 54 |
| TotalUS$'000 | 198,652 | 153,734 | 178,651 | 189,334 | PDF p. 54 |
Revenues are attributed to countries on the basis of the customer's location, irrespective of the origin of the goods and services. The non-current assets are analysed by the geographical area in which the assets are located. The non-current assets exclude any financial instruments and deferred tax assets.
Revenue of approximately US$165,315,000 (2024 : US$96,855,000) were derived from four (2024: three) major customers of the group. These revenues are attributable to the group's plantation segment.
33A: Segment reporting is not presented as the group is primarily engaged in the palm oil plantation business; the measurement of profit or loss used by the chief operating decision makers is on a group basis.
Debt
| Item / unit | 2025Less than 1 year, US$'000 | 20252 – 3 years, US$'000 | 20254 – 5 years, US$'000 | 2025Over 5 years, US$'000 | 2025Total, US$'000 | Source |
|---|---|---|---|---|---|---|
| Non-derivative financial liabilities, 2025 | ||||||
| Gross borrowingsUS$'000 | 48,700 | 61,812 | 43,773 | 33,009 | 187,294 | PDF p. 52 |
| Gross lease liabilitiesUS$'000 | 1,606 | 1,504 | – | – | 3,110 | PDF p. 52 |
The above amounts are contractual undiscounted cash flows and differ from the amount included in the statement of financial position.
| Item / unit | 2025Less than 1 year, US$'000 | 20252 – 3 years, US$'000 | 20254 – 5 years, US$'000 | 2025Over 5 years, US$'000 | 2025Total, US$'000 | 2024Less than 1 year, US$'000 | 20242 – 3 years, US$'000 | 20244 – 5 years, US$'000 | 2024Over 5 years, US$'000 | 2024Total, US$'000 | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-derivative financial liabilities, | |||||||||||
| Gross borrowingsUS$'000 | 48,700 | 61,812 | 43,773 | 33,009 | 187,294 | 67,538 | 71,757 | 51,448 | 41,060 | 231,803 | PDF p. 52 |
| Gross lease liabilitiesUS$'000 | 1,606 | 1,504 | – | – | 3,110 | 1,536 | 849 | 3 | – | 2,388 | PDF p. 52 |
The above amounts are contractual undiscounted cash flows and differ from the amount included in the statement of financial position.
Same table as 2025 block, 2024 comparative.
| Item / unit | 2025US$'000 | 2024US$'000 | Source |
|---|---|---|---|
| Non-current, floating interest rates | |||
| Investment loans (secured) (Note 26A)US$'000 | 109,191 | 132,232 | PDF p. 48 |
| Term loans (secured) (Note 26A)US$'000 | 5,554 | 2,546 | PDF p. 48 |
| Current, floating interest rates | |||
| Bank loans (secured) (Note 26A)US$'000 | 10,726 | 29,041 | PDF p. 48 |
| Investment loans (secured) (Note 26A)US$'000 | 25,423 | 24,820 | PDF p. 48 |
| Term loans (secured) (Note 26A)US$'000 | 2,620 | 1,526 | PDF p. 48 |
| Total | |||
| Total other financial liabilitiesUS$'000 | 153,514 | 190,165 | PDF p. 48 |
Non-current subtotal 114,745 (2025) and 134,778 (2024); current subtotal 38,769 (2025) and 55,387 (2024) are printed unlabelled. All borrowings are secured and floating rate. The bank overdrafts and other secured banking facilities are covered by way of negative pledges on certain deposits, inventories, receivables, land use rights, property, plant and equipment, bearer plants and biological assets of the group.
| Item / unit | 2025interest rate range | 2024interest rate range | Source |
|---|---|---|---|
| Term loans – secured | |||
| Indonesian Rupiah% per annum | 9.50 | 10.50 | PDF p. 48 |
| Singapore dollar% per annum | 3.19 | 4.86 | PDF p. 48 |
The floating rate loans are with interest rates that are re-set regularly at one to three months intervals.
| Item / unit | 2025US$'000 | 2024US$'000 | Source |
|---|---|---|---|
| Lease liabilities | |||
| Lease liabilities, currentUS$'000 | 1,409 | 1,398 | PDF p. 49 |
| Lease liabilities, non-currentUS$'000 | 1,410 | 794 | PDF p. 49 |
| TotalUS$'000 | 2,819 | 2,192 | PDF p. 49 |
The average lease term is 3 years (2024: 3 years). The fixed rate of interest for the leases is about 4.1% to 13.5% (2024: 4.1% to 13.5%) per year. All leases are on a fixed repayment basis and no arrangements have been entered into for contingent rental payments. The obligations under leases are secured by the lessor’s charge over the right-of-use assets. A summary of the maturity analysis of lease liabilities is disclosed in Note 32E.
| Item / unit | 2025US$'000 | 2024US$'000 | Source |
|---|---|---|---|
| Financial liabilities with interest | |||
| Floating rateUS$'000 | 153,514 | 190,165 | PDF p. 53 |
| Fixed rateUS$'000 | 2,819 | 2,192 | PDF p. 53 |
| Total at end of yearUS$'000 | 156,333 | 192,357 | PDF p. 53 |
| Bank facilities | |||
| Undrawn borrowing facilitiesUS$'000 | 38,632 | 5,759 | PDF p. 53 |
Company column printed as '–' for financial liabilities with interest in both years and not extracted. Currency note: SGD-denominated borrowings of (249) in 2025 and (369) in 2024 US$'000 are shown in Note 32G.
Payout
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Dividend policy | The Company does not have a fixed dividend policy at present. | Company/Group, FY2025 | PDF p. 21 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| final tax exempt (one-tier) dividend | 0.015 SGD per ordinary share | Final dividend proposed for FY2025, per ordinary share; subject to shareholder approval at 2026 AGM | PDF p. 21 |
Extracted from KENCANA AGRI LIMITED ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.
Auditor’s report
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Audit firm | RSM SG Assurance LLP | Group and company, year ended 31 December 2025 | PDF p. 30 |
| Engagement partner | Chow Khen Seng | Group and company, year ended 31 December 2025 | PDF p. 30 |
| Opinion | true and fair view | Group and company, year ended 31 December 2025 | PDF p. 29 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Impairment assessment of the company’s cost of investments and other receivables from subsidiaries and the group’s non-current non-financial assets | Management’s assessment of impairment allowance is significant as the recoverable amount of the CGU is measured by value-in-use method which is complex, judgmental and subjective, particularly given the changes in market and economic conditions. | Company and group | PDF p. 29 |
Extracted from KENCANA AGRI LIMITED ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.
Group and parent company or bank figures are labelled separately. Parentheses indicate negative amounts; a dash and NA retain the report’s notation.
Comparative figures follow KENCANA AGRI LIMITED ANNUAL REPORT 2025, including retrospective adjustments. Adjusted and reported earnings may have different definitions; refer to each statement’s notes.
These tables show the available extracted figures. The original annual report contains the full statements, notes and definitions.